{
    "title": "109_s2115",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Morris K. Udall Parkinson's Disease \nResearch Act Amendments of 2005''.\n\nSEC. 2. MORRIS K. UDALL PARKINSON'S DISEASE RESEARCH ACT OF 1997.\n\n    (a) Findings.--Subsection (b) of section 603 of the Morris K. Udall \nParkinson's Disease Research Act of 1977 (42 U.S.C. 284f note) is \namended by striking paragraph (1) and inserting the following:\n            ``(1) Finding.--Congress finds that, to take full advantage \n        of the tremendous potential for finding a cure or effective \n        treatment, the Federal investment in Parkinson's must be \n        expanded, as well as the coordination strengthened among the \n        National Institutes of Health research institutes.''.\n    (b) Public Health Service Act.--Section 409B of the Public Health \nService Act (42 U.S.C. 284f) is amended--\n            (1) in subsection (b), by striking paragraph (2) and \n        inserting the following:\n            ``(2) Conference.--\n                    ``(A) In general.--The Director of NIH shall \n                convene a coordinating and planning conference every 2 \n                years with relevant institutes and non-governmental \n                organizations to conduct a thorough investigation of \n                all Parkinson's research that is funded in whole or in \n                part by the National Institutes of Health and to \n                identify shortcomings and opportunities for more \n                effective treatments and a cure for Parkinson's \n                disease. The Director shall report to Congress on the \n                coordination among the institutes in carrying out such \n                research.\n                    ``(B) Research investment plan.--\n                            ``(i) In general.--The results of each \n                        conference convened under subparagraph (A) \n                        shall be included in a research investment plan \n                        that provides for measurable results with the \n                        goals of better treatments and a cure for \n                        Parkinson's disease being the determining \n                        factors in the allocation of Parkinson's \n                        disease research dollars. The plan shall \n                        include an outline of the manner in which to \n                        fully utilize the Udall Center program to \n                        ensure the continuation of a particular focus \n                        on translational research, including a clinical \n                        component.\n                            ``(ii) Budget and implementation \n                        strategy.--The plan submitted under clause (i) \n                        shall include a budget (that includes both \n                        programmatic and dollar line items) and \n                        implementation strategy (that incorporates the \n                        use of special initiatives such as Requests for \n                        Applications, Program Announcements with set-\n                        asides or similar directed research mechanisms) \n                        together with results to be reported back to \n                        Congress.\n                    ``(C) Submissions to congress.--The plan under \n                subparagraph (B) (including the budget and \n                implementation strategy) and the expected results of \n                plan implementation shall be submitted to Congress not \n                later than 3 months after the conference is convened \n                under subparagraph (A). Reports on the outcomes of the \n                plan, including actual spending and actual results, \n                shall be submitted to Congress on an annual basis.\n                    ``(D) Funding.--The Secretary shall ensure that \n                adequate funding is available under this section to \n                carry out the activities described in the investment \n                plan under subparagraph (B).'';\n            (2) in subsection (c)--\n                    (A) in paragraph (1)--\n                            (i) by striking ``not more than 10''; and\n                            (ii) by adding at the end the following: \n                        ``The Director shall ensure that an additional \n                        center shall be funded under this paragraph to \n                        serve as the coordinating center to coordinate \n                        the activities conducted by each of the centers \n                        funded under this paragraph to further focus \n                        and manage the interdisciplinary efforts of \n                        such centers.'';\n                    (B) in paragraph (2)(A)(ii), by striking ``conduct \n                basic and clinical research'' and inserting ``in \n                carrying out research, ensure that a significant \n                clinical component is provided for in addition to \n                ongoing basic research''; and\n                    (C) by adding at the end the following:\n            ``(5) Review process.--The Director of NIH shall establish \n        a review process with respect to applications received for \n        grants under paragraph (1). Such process shall provide for the \n        evaluation of applicants in a manner that recognizes the unique \n        aspects of the clinical, coordination, and multidisciplinary \n        components of the applicants.'';\n            (3) in subsection (d)--\n                    (A) by striking ``is authorized to establish a \n                grant program'' and inserting ``shall award grants''; \n                and\n                    (B) by inserting before the period at the end the \n                following: ``and shall be awarded in a manner \n                consistent with the research investment plan under \n                subsection (b)(2)(B)''; and\n            (4) by striking subsection (e) and inserting the following:\n    ``(e) Report.--The Director of NIH, in consultation with the \nDirector of the Centers for Disease Control and Prevention, shall \nconduct an investigation, and prepare and submit to the appropriate \ncommittees of Congress a report, on the incidence of Parkinson's \ndisease, including age, occupation, and geographic population clusters, \nand related environmental factors relating to such disease.\n    ``(f) Authorization of Appropriations.--For the purposes of \ncarrying out this section, section 301, and this title with respect to \nresearch focused on Parkinson's disease, there are authorized to be \nappropriated not to exceed such sums as may be necessary for each of \nfiscal years 2007 through 2012.''."
}